These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 73187)

  • 1. Reactions in canine skin with human leukocyte lysates.
    Tomar RH; Terzian J
    Proc Soc Exp Biol Med; 1977 Nov; 156(2):247-50. PubMed ID: 73187
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative studies on dialyzable leukocyte extracts containing transfer factor--a review.
    Klesius PH; Fudenberg HH; Smith CL
    Comp Immunol Microbiol Infect Dis; 1980; 3(3):247-60. PubMed ID: 6162606
    [No Abstract]   [Full Text] [Related]  

  • 3. [The isolation of a transfer factor of the delayed-hypersensitivity type to the antigenic substances of Staphylococcus aureus in guinea pigs].
    Holieva OH; Liubchenko TA; Kholodna LS; Vershihora AIu
    Fiziol Zh (1994); 1996; 42(5-6):58-65. PubMed ID: 9044813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculin-specific transfer factor in dogs.
    Simon MR; Silva J; Freier D; Bruner J; Wiliams R
    Infect Immun; 1977 Oct; 18(1):73-7. PubMed ID: 908623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfer factor: specific and nonspecific effects and chemical characteristics of dialyzable leukocyte lysates (DLL). Part I. Introduction. (first of three parts).
    Ablin RJ
    Allergol Immunopathol (Madr); 1980; 8(1):53-60. PubMed ID: 6996464
    [No Abstract]   [Full Text] [Related]  

  • 6. Transfer of delayed cutaneous hypersensitivity with transfer factor.
    Kirkpatrick CH
    Cell Immunol; 1978 Nov; 41(1):62-71. PubMed ID: 719770
    [No Abstract]   [Full Text] [Related]  

  • 7. Mononuclear cells contain human transfer factor as assayed locally on the skin of dogs.
    Tomar RH; John PA
    J Immunol; 1979 Aug; 123(2):590-3. PubMed ID: 458148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and molecular events in the delayed-onset hypersensitivities.
    Godfrey HP; Gell PG
    Rev Physiol Biochem Pharmacol; 1978; 84():1-92. PubMed ID: 82989
    [No Abstract]   [Full Text] [Related]  

  • 9. Transfer factor: specific and nonspecific effects and chemical characteristics of dialyzable leukocyte lysates (DLL). Part III. Biochemical characterization. (third of three parts).
    Ablin RJ
    Allergol Immunopathol (Madr); 1980; 8(3):203-12. PubMed ID: 7405767
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of dialyzable products from human leukocyte extracts on cutaneous delayed-hypersensitivity response.
    Gottlieb AA; Maziarz GA; Tamaki N; Sutcliffe SB
    J Immunol; 1980 Feb; 124(2):885-92. PubMed ID: 7356716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed hypersensitivity and transfer factor in experimental coccidioidomycosis.
    Likholetov SM
    Sabouraudia; 1979 Sep; 17(3):251-9. PubMed ID: 93786
    [No Abstract]   [Full Text] [Related]  

  • 12. Bovine transfer factor: in vivo transfer of cell-mediated immunity to cattle with alcohol precipitates.
    Klesius PH; Fudenberg HH
    Clin Immunol Immunopathol; 1977 Sep; 8(2):238-46. PubMed ID: 902438
    [No Abstract]   [Full Text] [Related]  

  • 13. Transfer factor and immunity: an introduction.
    Sutcliffe SB; Maziarz G; Gottlieb AA
    Ann N Y Acad Sci; 1979; 332():184-6. PubMed ID: 93860
    [No Abstract]   [Full Text] [Related]  

  • 14. Modulation of cell-mediated responses with dialyzable leukocyte extract containing transfer factor.
    Klesius PH
    Adv Exp Med Biol; 1981; 137():293-323. PubMed ID: 6174037
    [No Abstract]   [Full Text] [Related]  

  • 15. [Transfer of delayed-type hypersensitivity to Candida albicans or Sporothrix schenkii and protection against experimental candidiasis with murine transfer factor].
    Kondoh Y; Shimizu K
    Nihon Saikingaku Zasshi; 1985 Sep; 40(5):835-42. PubMed ID: 2416963
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro studies with "transfer factor". II. Transfer of the cell-migration inhibition correlate of delayed hypersensitivity in humans with nondialyzable components of leucocyte lysates from humans sensitized to histoplasmin and coccidioidin.
    Paque RE; Dray S; Kniskern P; Baram P
    Cell Immunol; 1973 Mar; 6(3):368-74. PubMed ID: 4691111
    [No Abstract]   [Full Text] [Related]  

  • 17. Murine transfer factor. II. Transfer of delayed hypersensitivity to synthetic antigens.
    Kirkpatrick CH; Rozzo SJ; Mascali JJ; Merryman CF
    J Immunol; 1985 Mar; 134(3):1723-7. PubMed ID: 2578518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Meaning of leukocyte migration inhibition in the presence of soluble antigens].
    Clot J; Mandin J
    Ann Inst Pasteur (Paris); 1972 Jul; 123(1):121. PubMed ID: 4640715
    [No Abstract]   [Full Text] [Related]  

  • 19. Atypical mycobacterium infection treated with dialyzable leukocyte extracts: evidence for antigenic specificity.
    Simon MR; Salberg DJ; Silva J; Ganji S; Desai S; Muller BF; Palutke M
    Clin Immunol Immunopathol; 1981 Jul; 20(1):123-8. PubMed ID: 6167387
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell-mediated immunity: correlation of mixed-leucocyte-macrophage migration inhibition with delayed-type hypersensitivity after immunization and donor-specific transfer of cell migration inhibition by dialyzable leucocyte extract.
    Mazaheri R; Hamblin AS; Zuckerman AJ
    Cell Immunol; 1983 Nov; 82(1):147-62. PubMed ID: 6196129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.